Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...
Sitagliptin, metformin (as HCl) ext-rel; 50mg/500mg, 50mg/1000mg, 100mg/1000mg; tabs. Individualize. Swallow whole. Take once daily with a meal, preferably in the evening. Not currently treated with ...
Do not use if you have ever had an allergic reaction to SITAGLIPTIN/METFORMIN MYLAN or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions ...
Expert Rev Endocrinol Metab. 2008;3(6):691-697. Elimination of sitagliptin occurs primarily via renal excretion (79%) and involves active tubular secretion. Sitagliptin is a substrate for human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results